Combinations Alliance
The Combinations Alliance utilises the expertise from the translational groups within the Experimental Cancer Medicine Centres (ECMC) network, to drive academic - industrial partnership, generating novel treatment options for people with cancer that would otherwise unlikely be realised. This Cancer Research UK model seeks novel agents from industry for investigation by ECMC researchers with hypothesis driven combination proposals in cancer including cancers of high unmet need and radiotherapy combinations, areas not traditionally supported by industry. It is aligned with Cancer Research UK’s vision to bring forward the day when all cancers are cured.
RESEARCHERS
Need support in translating your early phase combination idea into a clinical trial? We can support you bring your early phase combination idea to clinic.
INDUSTRY
Keen to broaden your portfolio with novel combinations? We can connect you to an expert academic early phase network.
Useful Links
Title
The Alliance facilitates access to world class scientists and medical centres and, importantly, creates an opportunity to explore combinations with some of the most promising investigational compounds currently in development. Being part of the Alliance significantly expands our potential to deliver transformative therapies to patients with many types of cancer.
Robert Forrester, Verastem